Key facts
- This page summarizes Keith Murphy's Form 4 filing for ORGANOVO HOLDINGS, INC. (VIVS).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 07 Aug 2024, 16:01.
Keith Murphy - 05 Aug 2024 Form 4 Insider Report for ORGANOVO HOLDINGS, INC. (VIVS)
- Reporting relationship
- EXECUTIVE CHAIRMAN, Director
- Issuer ticker
- VIVS
- Reported as of
- 05 Aug 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Aug 2024, 16:01:03 UTC
- Prior SEC filing
- 17 Nov 2023
- Next SEC filing
- 17 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Keith Murphy
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Keith Murphy filed Form 4 for ORGANOVO HOLDINGS, INC. (VIVS) on 07 Aug 2024.
Change
- Previous filing in this sequence was filed on 17 Nov 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ONVO
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +19,607
- Change %
- +17%
- Price
- $0.000000
- Shares after
- 132,641
- Date
- 07 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ONVO
transaction
Derivative
Options (right to buy)
Award
- Transaction value
- $0
- Shares
- +574,923
- Change %
- Price
- $0.000000
- Shares after
- 574,923
- Date
- 05 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 574,923
- Exercise price
- $0.5368
- Footnotes
- F2
ONVO
transaction
Derivative
Options (right to buy)
Award
- Transaction value
- $0
- Shares
- +143,731
- Change %
- Price
- $0.000000
- Shares after
- 143,731
- Date
- 05 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 143,731
- Exercise price
- $0.5368
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The reported securities are represented by restricted stock units, which shall vest on the earlier of August 7, 2025 or the date of the annual meeting of stockholders held by the Issuer in 2025, subject to acceleration in the event of a change of control.
Footnote F2
The option vests in 3 equal annual installments on each of August 5, 2025, August 5, 2026 and August 5, 2027.
Footnote F3
The option becomes exercisable if, after the grant date, the closing sales price of the Common Stock, as reported on the Nasdaq Capital Market (based on a 90-trading day average), is at least $1.53 (subject to adjustment for stock splits), as confirmed by the Board of Directors or a committee thereof.